Cargando…
Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes
The incidence and prevalence of diabetes are increasing worldwide, and cardiovascular disease (CVD) is the leading cause of death among subjects with type 2 diabetes (T2D). The assessment and stratification of cardiovascular risk in subjects with T2D is a challenge. Advanced glycation end products a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181586/ https://www.ncbi.nlm.nih.gov/pubmed/35682915 http://dx.doi.org/10.3390/ijms23116234 |
_version_ | 1784723812999233536 |
---|---|
author | Planas, Alejandra Simó-Servat, Olga Hernández, Cristina Simó, Rafael |
author_facet | Planas, Alejandra Simó-Servat, Olga Hernández, Cristina Simó, Rafael |
author_sort | Planas, Alejandra |
collection | PubMed |
description | The incidence and prevalence of diabetes are increasing worldwide, and cardiovascular disease (CVD) is the leading cause of death among subjects with type 2 diabetes (T2D). The assessment and stratification of cardiovascular risk in subjects with T2D is a challenge. Advanced glycation end products are heterogeneous molecules produced by non-enzymatic glycation of proteins, lipids, or nucleic acids. Accumulation of advanced glycation end products is increased in subjects with T2D and is considered to be one of the major pathogenic mechanism in developing complications in diabetes. Skin AGEs could be assessed by skin autofluorescence. This method has been validated and related to the presence of micro and macroangiopathy in individuals with type 2 diabetes. In this context, the aim of this review is to critically summarize current knowledge and scientific evidence on the relationship between skin AGEs and CVD in subjects with type 2 diabetes, with a brief reference to other diabetes-related complications. |
format | Online Article Text |
id | pubmed-9181586 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91815862022-06-10 Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes Planas, Alejandra Simó-Servat, Olga Hernández, Cristina Simó, Rafael Int J Mol Sci Review The incidence and prevalence of diabetes are increasing worldwide, and cardiovascular disease (CVD) is the leading cause of death among subjects with type 2 diabetes (T2D). The assessment and stratification of cardiovascular risk in subjects with T2D is a challenge. Advanced glycation end products are heterogeneous molecules produced by non-enzymatic glycation of proteins, lipids, or nucleic acids. Accumulation of advanced glycation end products is increased in subjects with T2D and is considered to be one of the major pathogenic mechanism in developing complications in diabetes. Skin AGEs could be assessed by skin autofluorescence. This method has been validated and related to the presence of micro and macroangiopathy in individuals with type 2 diabetes. In this context, the aim of this review is to critically summarize current knowledge and scientific evidence on the relationship between skin AGEs and CVD in subjects with type 2 diabetes, with a brief reference to other diabetes-related complications. MDPI 2022-06-02 /pmc/articles/PMC9181586/ /pubmed/35682915 http://dx.doi.org/10.3390/ijms23116234 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Planas, Alejandra Simó-Servat, Olga Hernández, Cristina Simó, Rafael Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes |
title | Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes |
title_full | Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes |
title_fullStr | Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes |
title_full_unstemmed | Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes |
title_short | Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes |
title_sort | advanced glycations end products in the skin as biomarkers of cardiovascular risk in type 2 diabetes |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181586/ https://www.ncbi.nlm.nih.gov/pubmed/35682915 http://dx.doi.org/10.3390/ijms23116234 |
work_keys_str_mv | AT planasalejandra advancedglycationsendproductsintheskinasbiomarkersofcardiovascularriskintype2diabetes AT simoservatolga advancedglycationsendproductsintheskinasbiomarkersofcardiovascularriskintype2diabetes AT hernandezcristina advancedglycationsendproductsintheskinasbiomarkersofcardiovascularriskintype2diabetes AT simorafael advancedglycationsendproductsintheskinasbiomarkersofcardiovascularriskintype2diabetes |